FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7712811000001107: Zentel 400mg chewable tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20637901000001114 Zentel 400mg chewable tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
43160901000001119 Zentel 400mg chewable tablets (Imported (United States)) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zentel 400mg chewable tablets (GlaxoSmithKline) Is a Albendazole 400mg chewable tablets true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) Has active ingredient Albendazole true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) Has manufactured dose form Conventional release chewable tablet false Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) Has specific active ingredient Albendazole true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) Has manufactured dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zentel 400mg chewable tablets (GlaxoSmithKline) 1 tablet Is pack of False Zentel 400mg chewable tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) 3 tablet Is pack of False Zentel 400mg chewable tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) 3 tablet Has AMP True Zentel 400mg chewable tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Zentel 400mg chewable tablets (GlaxoSmithKline) 1 tablet Has AMP True Zentel 400mg chewable tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start